These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9451724)

  • 21. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
    Gulati A; Arora RC; Crayton J
    Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H] imipramine binding in brain samples from depressed suicides and controls: 5-HT uptake sites compared with sites defined by desmethylimipramine.
    Lawrence KM; Kanagasundaram M; Lowther S; Katona CL; Crompton MR; Horton RW
    J Affect Disord; 1998 Jan; 47(1-3):105-12. PubMed ID: 9476750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of MAO activity, 3H-imipramine binding, 3H-paroxetine binding and 3H-5-HT uptake by human cerebrospinal fluid.
    Egashira T; Goto S; Murayama F; Yamanaka Y
    J Neural Transm Suppl; 1990; 32():447-56. PubMed ID: 2150970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
    Lawrence KM; Falkowski J; Jacobson RR; Horton RW
    Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.
    Naylor L; Dean B; Opeskin K; Pavey G; Hill C; Keks N; Copolov D
    J Neural Transm (Vienna); 1996; 103(6):749-57. PubMed ID: 8836936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
    Dean B; Hayes W; Opeskin K; Naylor L; Pavey G; Hill C; Keks N; Copolov DL
    Behav Brain Res; 1996; 73(1-2):169-75. PubMed ID: 8788497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.
    Cheetham SC; Viggers JA; Slater NA; Heal DJ; Buckett WR
    Neuropharmacology; 1993 Aug; 32(8):737-43. PubMed ID: 8413837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.
    Raisman R; Cash R; Agid Y
    Neurology; 1986 Apr; 36(4):556-60. PubMed ID: 2938025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aging and 3H-paroxetine binding in rat brain: effect of imipramine and tetrahydroacridine.
    Arora RC; Gulati A; Crayton JW
    Life Sci; 1993; 52(22):1767-75. PubMed ID: 8492639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders.
    Marcusson JO; Alafuzoff I; Bäckström IT; Ericson E; Gottfries CG; Winblad B
    Brain Res; 1987 Nov; 425(1):137-45. PubMed ID: 3427415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet serotonergic binding sites in alcohol-dependent patients.
    Arranz B; Rosel P; Sarró S; Zaldivar E; Cano R; Navarro MA; San L
    Alcohol Alcohol; 1999; 34(5):726-32. PubMed ID: 10528815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
    Nadgir SM; Malviya M
    Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
    Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
    J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
    Bäckström I; Bergström M; Marcusson J
    Brain Res; 1989 May; 486(2):261-8. PubMed ID: 2525060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
    Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
    Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age stability of human brain 5-HT terminals studied with [3H]paroxetine binding.
    Andersson A; Sundman I; Marcusson J
    Gerontology; 1992; 38(3):127-32. PubMed ID: 1385585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.